Standards of Medical Care in Diabetes—2008
Response to Dora, Kramer, and Canani
- Irl B. Hirsch, MD12,
- Silvio E. Inzucchi, MD13 and
- M. Sue Kirkman, MD4
- 1Professional Practice Committee of the American Diabetes Association, Alexandria, Virginia
- 2University of Washington, Seattle, Washington
- 3Yale University, New Haven, Connecticut
- 4American Diabetes Association, Alexandria, Virginia
- Corresponding author: M. Sue Kirkman, MD, 1701 N. Beauregard St., Alexandria, VA 22311. E-mail: skirkman{at}diabetes.org
We thank Dora, Kramer, and Canani (1) for their interest in the Standards of Medical Care in Diabetes—2008 (2) and their critique of the recommendations for aspirin for primary prevention of cardiovascular disease (CVD). The American Diabetes Association's “A”-level evidence also encompasses supportive evidence from a meta-analysis incorporating quality ratings. Supportive evidence can derive from studies in people without diabetes but at similar CVD risk.
The systematic review of evidence for the U.S. Preventive Services Task Force estimated that aspirin …
